Gut microbiota metabolism of L-carnitine and cardiovascular risk [PMID: 24267266] Laboratory literature summary: Gut microbiota metabolism of L-carnitine and cardiovascular risk
Patients may also experience some mild side effects, such as nausea, gastrointestinal symptoms like diarrhea or constipation, and headaches
Theyve helped me lose and maintain my weight and my sanity
The distribution is polarized
Moreover, researchers are exploring whether different GLP-1 agonists (such as semaglutide and liraglutide ) vary in effectiveness for different types of addiction, and whether individual factors such as age, gender, or genetic makeup influence how well these treatments work
As Healio previously reported, a study by Bian and colleagues published earlier this year showed older adults with cancer and type 2 diabetes who used GLP-1 receptor agonists exhibited significantly lower risk for all-cause mortality than those treated with dipeptidyl peptidase-4 inhibitors